| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0254926a58b3d3b2adcae086dc996f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f465a288a8bbf24a010536ce8d2f08e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0672f7d4ea7063bee9b6496d7c47bbd1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1fd67e5eb919a128348cc32fe69f8f7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 |
| filingDate |
2000-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5718c7a77abd8578518a1186b89ab1b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60b59a529980217d31ad7035259d9d7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8068f61400a1dbbefa01c7539a25fc72 |
| publicationDate |
2000-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0061118-A1 |
| titleOfInvention |
Anhydrous tablet of ranitidine hydrochloride with double-layer coating and its composition |
| abstract |
The invention concerns an anhydrous tablet containing anhydrous ranitidine hydrochloride, coated by a double-layer coating, its composition and the relevant process of preparation. The anhydrous tablet of the invention is characterized by the direct dry tabletting, without using water, of a mixture consisting of the active ingredient anhydrous ranitidine hydrochloride, in the crystalline form 'allomorphous Form 1' having a particular purity and stability, and by a global amount of other excipients and adjuvant substances or inert vehicles less than the weight of the active ingredient. Moreover, the anhydrous tablet of the invention is characterized by a high percentage of disintegrating substance in the tabletting mixture and by a special two-layer coating. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105030694-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BG-65305-B1 |
| priorityDate |
1999-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |